Genetic mutation

Pro-EYS

Sep 30 2020

Rate of Progression in EYS Related Retinal Degeneration (Pro-EYS).

Read More

AGTC A3

Sep 30 2020

A Multiple-Site, Phase 1/2, Safety and Efficacy Trial of AGTC 402, a Recombinant Adeno-associated Virus Vector Expressing CNGA3, in Patients with Congenital Achromatopsia Caused by Mutations in the CNGA3 Gene Sponsor: Applied Genetic Technologies Corp…

Read More

AGTC B3

Sep 30 2020

A Multiple-Site, Phase 1/2, Safety and Efficacy Trial of a Recombinant Adeno-associated Virus Vector Expressing CNGB3 (rAAV2tYF-PR1.7-hCNGB3) in Patients with Congenital Achromatopsia Caused by Mutations in the CNGB3 Gene Sponsor: Applied Genetic Technologies Corp visit…

Read More